Insider: Farwell Wildon Chief Medical Officer - Dyne Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 143,222 | 0 | 143,222 |
| Value | $1,801,732.76 | $0.00 | $1,801,732.76 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/19/2024 | DDS | 261 | Direct | COM | $46.00 | $12,006.00 | 143,222 |
| 08/19/2024 | DDS | 2,060 | Direct | COM | $45.01 | $92,720.60 | 143,483 |
| 06/11/2024 | DDS | 1,628 | Direct | COM | $31.27 | $50,907.56 | 146,551 |
| 06/11/2024 | DDS | 1,008 | Direct | COM | $31.27 | $31,520.16 | 145,543 |
| 05/16/2024 | DDS | 1,956 | Direct | COM | $28.20 | $55,159.20 | 148,604 |
| 05/16/2024 | DDS | 425 | Direct | COM | $28.59 | $12,150.75 | 148,179 |
| 03/12/2024 | DDS | 1,030 | Direct | COM | $25.58 | $26,347.40 | 150,560 |
| 03/11/2024 | DDS | 1,585 | Direct | COM | $25.70 | $40,734.50 | 151,590 |
| 03/07/2024 | DDS | 8,364 | Direct | COM | $25.80 | $215,791.20 | 154,732 |
| 03/07/2024 | DDS | 1,557 | Direct | COM | $26.20 | $40,793.40 | 153,175 |
| 02/28/2024 | DDS | 407 | Direct | COM | $25.00 | $10,175.00 | 163,096 |
| 02/12/2024 | DDS | 5,493 | Direct | COM | $25.07 | $137,709.51 | 163,503 |
| 01/26/2024 | DDS | 100 | Direct | COM | $25.00 | $2,500.00 | 168,996 |
| 12/12/2023 | DDS | 978 | Direct | COM | $10.55 | $10,317.90 | 169,096 |
| 12/11/2023 | DDS | 1,688 | Direct | COM | $10.72 | $18,095.36 | 170,074 |
| 09/12/2023 | DDS | 1,707 | Direct | COM | $10.41 | $17,769.87 | 89,250 |
| 06/13/2023 | DDS | 1,698 | Direct | COM | $12.43 | $21,106.14 | 90,957 |
| 03/14/2023 | DDS | 7,441 | Direct | COM | $13.33 | $99,188.53 | 92,655 |
| 12/12/2022 | DDS | 628 | Direct | COM | $10.87 | $6,826.36 | 100,096 |
| 03/11/2022 | DDS | 640 | Direct | COM | $8.73 | $5,587.20 | 66,050 |
| 03/02/2022 | DDS | 5,617 | Direct | COM | $8.56 | $48,081.52 | 66,690 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research